Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 01, 2023 16:05 ET | Source: Exagen Inc.

Exagen Announces Campaign for Lupus Awareness Month

SAN DIEGO, May 01, 2023 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced, in recognition of Lupus Awareness Month, the launch of a...
April 24, 2023 16:05 ET | Source: Exagen Inc.

Exagen to Announce First Quarter 2023 Financial Results on May 15, 2023

SAN DIEGO, April 24, 2023 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, will release financial results for the quarter ended March 31, 2023,...
March 20, 2023 16:05 ET | Source: Exagen Inc.

Exagen Inc. Reports Fourth Quarter and Full Year 2022 Results

SAN DIEGO, March 20, 2023 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today reported financial results for the fourth quarter and full year...
March 06, 2023 16:05 ET | Source: Exagen Inc.

Exagen to Announce Fourth Quarter and Full Year Financial Results on March 20, 2023

SAN DIEGO, March 06, 2023 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, will release financial results for the quarter and year ended December...
February 27, 2023 09:00 ET | Source: Exagen Inc.

Exagen Inc. to Participate in Upcoming March Conferences

SAN DIEGO, Feb. 27, 2023 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced that management will participate in the following March...
January 30, 2023 16:05 ET | Source: Exagen Inc.

Exagen Inc. to Participate in the 2023 BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference

SAN DIEGO, Jan. 30, 2023 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced its participation in the BTIG MedTech, Digital Health,...
January 23, 2023 09:00 ET | Source: Exagen Inc.

Exagen Inc. Elects Tina S. Nova, Ph.D. as Executive Chair of the Board of Directors

SAN DIEGO, Jan. 23, 2023 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, announced today that Tina S. Nova, Ph.D. has been elected as Executive...
November 14, 2022 16:05 ET | Source: Exagen Inc.

Exagen Inc. Reports Third Quarter 2022 Results

SAN DIEGO, Nov. 14, 2022 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today reported financial results for the quarter ended September 30, 2022....
November 08, 2022 16:05 ET | Source: Exagen Inc.

Exagen Inc. to Participate in Fourth Quarter Investor Conferences

SAN DIEGO, Nov. 08, 2022 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced that management will participate in the following fourth...
October 31, 2022 16:05 ET | Source: Exagen Inc.

Exagen to Announce Third Quarter 2022 Financial Results on November 14, 2022

SAN DIEGO, Oct. 31, 2022 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, will release financial results for the quarter ended September 30, 2022,...